Degrees:
2006
Doctorate Medical and Health Sciences incl Neurosciences
2023
Doctorate Mathematical sciences
Applied Statistics to Biomedical Sciences
Publications resulting from Research
Ortiz Carrodeguas, R. A., et al. (2024). "Safety and effectiveness of CIMAvax-EGF administered in community polyclinics." Frontiers in Oncology 13: 1287902.
De Witte, D., et al. (2023). "A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in Cuba." Spatial and Spatio-temporal Epidemiology 45: 100588.
Sánchez, Y., et al. (2023). "Nimotuzumab Concurrent with Gemcitabine as First‐Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma." BioMed Research International 2023(1): 1496072.
Diaz, H., et al. (2022). "Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario." Frontiers in Public Health 10: 948520.
Alonso A et al. (2022). "Identifying individual predictive factors for treatment efficacy". Biometrics. 78(1):35-45.
Más-Bermejo, P. I., et al. (2022). "Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study." The Lancet Regional Health–Americas 18:100422
Caballero, A., et al. (2020). "Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab." Clinical & Translational Immunology 9(11): e1218.
Lorenzo-Luaces, P., et al. (2020). "Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients." BMC cancer 20: 1-8.
Sanchez, L., et al. (2018). Differential effects of two therapeutic cancer vaccines on short-and long-term survival populations among patients with advanced lung cancer. Seminars in Oncology, 45(1-2):52-57.
Sebrango-Rodríguez, C. R., et al. (2017). "Real-time parameter estimation of Zika outbreaks using model averaging." Epidemiology & Infection 145(11): 2313-2323.
COMPUMAT
2025
BioHabana
2025
Moving from COVID-19 Mathematical Models to Vaccine Desing: Theory, Practice and Experiences
2025